Angiotensin converting enzyme is involved in the cardiac hypertrophy induced by sinoaortic denervation in rats

Cardiovascular Pathology

Volumn 24, Issue 1, 2015, Pages 41-48

  Lu, Lu ^a   Guo, Li ^b   Xie, Ting Ting ^a   Xin, Hai Li ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b Puhuangyu Clinic   (China)

Author keywords

Angiotensin converting enzyme; Angiotensin II; B2 kinin receptor; Left ventricular hypertrophy; Sinoaortic denervation

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE; ICATIBANT; KININ; LOSARTAN; MESSENGER RNA; RAMIPRIL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART DENERVATION; HEART LEFT VENTRICLE HYPERTROPHY; INFLAMMATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; AORTA; CARDIOMEGALY; DENERVATION; INNERVATION; METABOLISM; PHYSIOLOGY; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPRAGUE DAWLEY RAT; SURGERY;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; AORTA; BLOTTING, WESTERN; CARDIOMEGALY; DENERVATION; MALE; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RENIN-ANGIOTENSIN SYSTEM;

EID: 84920742570     PISSN: 10548807     EISSN: 18791336     Source Type: Journal    
DOI: 10.1016/j.carpath.2014.08.006     Document Type: Article

References (32)

1. Su DF, Chen L, Kong XB, Cheng Y. Determination of arterial baroreflex-blood pressure control in conscious rats. Acta Pharmacol Sin 2002;23:103-9.
2. Van-Vliet BN, Montani JP. Baroreflex stabilization of the double product. Am J Physiol 1999;277:H1679-89.
3. Norman RG, Coleman TG, Dent AC. Continuous monitoring of arterial pressure indicates sinoaortic denervated rats are not hypertensive. Hypertension 1981;3:119-25.
4. Saito M, Terui N, Numao N, Kumada M. Absence of sustained hypertension in sinoaortic-denervated rabbits. Am J Physiol 1986;251:H742-7.
5. Buchholtz RA, Nathan NA. Chronic lability of the arterial pressure produced by electrolytic lesions of the nucleus tractus solitarii in the rat. Circ Res 1984;54:227-38.
6. Su DF, Miao CY. Blood pressure variability and organ damage. Clin Exp Pharmacol Physiol 2001;28:709-15.
7. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship of 24-h blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens 1987;5:93-8.
8. Mancia G, Frattola A, Parati G, Santucciu C, Ulian L. Blood pressure variability and organ damage. J Cardiovasc Pharmacol 1994;24(Suppl. A):S6-S11.
9. Miao CY, Tao X, Gong K, Zhang SH, Chu ZX, Su DF. Aterial remodeling in chronic sinoaortic-denervated rats. J Cardiovasc Pharmacol 2001;37:6-15.
10. Vukelic S, Griendling KK. Angiotensin II, from vasoconstrictor to growth factor: a paradigm shift. Circ Res 2014;114:754-7.
11. De Mello WC, Frohlich ED. Clinical perspectives and fundamental aspects of local cardiovascular and renal renin-angiotensin systems. Front Endocrinol (Lausanne) 2014;5:16.
12. Hussain W, Patel PM, Chowdhury RA, Cabo C, Ciaccio EJ, Lab MJ, et al. The renin-angiotensin system mediates the effects of stretch on conduction velocity, connexin43 expression, and redistribution in intact ventricle. J Cardiovasc Electrophysiol 2010;21:1276-83.
13. Obata J, Nakamura T, Takano H, Naito A, Kimura H, Yoshida Y, et al. Increased gene expression of components of the renin-angiotensin system in glomeruli of genetically hypertensive rats. J Hypertens 2000;18:1247-55.
14. Li L, Yi-Ming W, Li ZZ, Zhao L, Yu YS, Li DJ, et al. Local RAS and inflammatory factors are involved in cardiovascular hypertrophy in spontaneously hypertensive rats. Pharmacol Res 2008;58:196-201.
15. Burger D, Reudelhuber TL, Mahajan A, Chibale K, Sturrock ED, Touyz RM. Effects of a domain-selective ACE inhibitor in a mouse model of chronic angiotensin II-dependent hypertension. Clin Sci (Lond) 2014;127:57-63.
16. Maeda A, Tamura K, Kanaoka T, Ohsawa M, Haku S, Azushima K, et al. Combination therapy of angiotensin II receptor blocker and calcium channel blocker exerts pleiotropic therapeutic effects in addition to blood pressure lowering: amlodipine and candesartan trial in Yokohama (ACTY). Clin Exp Hypertens 2012;34:249-57.
17. Tom B, Dendorfer A, Danser AH. Bradykinin, angiotensin-(1-7), and ACE inhibitors: how do they interact? Int J Biochem Cell Biol 2003;35:792-801.
18. Ishigai Y, Mori T, Ikeda T, Fukuzawa A, Shibano T. Role of bradykinin-NO pathway in prevention of cardiac hypertrophy by ACE inhibitor in rat cardiomyocytes. Am J Physiol 1997;273:H2659-63.
19. Miao CY, Xie HH, Wang JJ, Su DF. Candesartan inhibits sinoaortic denervation-induced cardiovascular hypertrophy in rats. Acta Pharmacol Sin 2002;23:713-20.
20. Liu JG, Xu LP, Chu ZX, Miao CY, Su DF. Contribution of blood pressure variability to the effect of nitrendipine on end-organ damage in spontaneously hypertensive rats. J Hypertens 2003;21:1961-7.
21. Fu YJ, Shu H, Miao CY, Wang MW, Su DF. Restoration of baroreflex function by ketanserin is not blood pressure dependent in conscious freely moving rats. J Hypertens 2004;22:1165-72.
22. Takemoto M, Egashira K, Tomita H, Usui M, Okamoto H, Kitabatake A, et al. Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis. Hypertension 1997;30:1621-7.
23. Li YL, Gao L, Zucker IH, Schultz HD. NADPH oxidase-derived superoxide anion mediates angiotensin II-enhanced carotid body chemoreceptor sensitivity in heart failure rabbits. Cardiovasc Res 2007;75:546-54.
24. Cingolani OH, Pérez NG, Ennis IL, Alvarez MC, Mosca SM, Schinella GR, et al. In vivo key role of reactive oxygen species and NHE-1 activation in determining excessive cardiac hypertrophy. Pflugers Arch 2011;462:733-43.
25. Araujo AS, Diniz GP, Seibel FE, Branchini G, Ribeiro MF, Brum IS, et al. Reactive oxygen and nitrogen species balance in the determination of thyroid hormones-induced cardiac hypertrophy mediated by renin-angiotensin system. Mol Cell Endocrinol 2011;333:78-84.
26. Hingtgen SD, Tian X, Yang J, Dunlay SM, Peek AS, Wu Y, et al. Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy. Physiol Genomics 2006;26:180-91.
27. Reckelhoff JF, Romero JC. Role of oxidative stress in angiotensininduced hypertension. Am J Physiol Regul Integr Comp Physiol 2003;284:R893-912.
28. Kayashima Y, Smithies O, Kakoki M. The kallikrein-kinin system and oxidative stress. Curr Opin Nephrol Hypertens 2012;21:92-6.
29. Dong R, Xu X, Li G, FengW, Zhao G, Zhao J, et al. Bradykinin inhibits oxidative stress-induced cardiomyocytes senescence via regulating redox state. PLoS One 2013;8:e77034.
30. Zhang C, Chen H, Xie HH, Shu H, Yuan WJ, Su DF. Inflammation is involved in the organ damage induced by sinoaortic denervation in rats. J Hypertens 2003;21:2141-8.
31. Wang Y, Li Y, Wu Y, Jia L, Wang J, Xie B, et al. TNF-α and IL-1β neutralization ameliorates angiotensin II-induced cardiac damage in male mice. Endocrinology 2014;155:2677-87.
32. Tang SC, Chan LY, Leung JC, Cheng AS, Chan KW, Lan HY, et al. Bradykinin and high glucose promote renal tubular inflammation. Nephrol Dial Transplant 2010;25:698-710.